PAA 0.00% 17.5¢ pharmaust limited

PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-435

  1. 12,141 Posts.
    lightbulb Created with Sketch. 6195
    But there is Value in the cupboard that could benefit PAA the company ,,, plus it was the basis for Human Cancer ,,,, so there is Value in proven Tech,, if the Current Management do not wish to pursue K9 Cancer then we need to realise the SH value already invested circa $39m was raised for K9 Cancer .

    Fully agree with not pursuing K9 Cancer but you don't just leave $39m in technology behind and not try and realise some value back into the company .... certainly prevent further dilution NZT

    Last edited by NZ Trader: 04/06/24
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
17.5¢
Change
0.000(0.00%)
Mkt cap ! $85.12M
Open High Low Value Volume
17.5¢ 18.0¢ 17.5¢ $50.92K 290.9K

Buyers (Bids)

No. Vol. Price($)
5 152309 17.5¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 329859 3
View Market Depth
Last trade - 15.48pm 11/09/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.